|
Model Number M00516750 |
Device Problem
Positioning Problem (3009)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 07/07/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
|
|
Event Description
|
It was reported to boston scientific corporation on september 29, 2018 that a wallflex esophageal fully covered stent was to be used to treat a malignant stricture due to esophageal cancer during an endoscopic retrograde cholangiopancreatography (ercp) with esophageal stent placement procedure performed on (b)(6) 2018.Reportedly, the patient's anatomy was not tight and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent fell into the stomach right after it was deployed in the esophagus.The stent was removed with forceps and another wallflex esophageal stent was placed to complete the procedure.There were no patient complications reported as a result of this event.The patient's condition following the procedure was reported to be stable.
|
|
Manufacturer Narrative
|
H6: problem code 3009 captures the reportable event of stent positioning/ placement problem.H10: a deployed wallflex esophageal fully covered stent and delivery system were returned for analysis.The stent was received fully expanded.Visual examination of the returned device identified no issues with the stent and delivery system.The stent was measured to be within specifications.The investigation concluded that procedural factors such as the handling of the device and normal procedural difficulties encountered during the procedure could have affected the device performance contributing to the reported event.Therefore, the most probable root cause is adverse event related to procedure.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly, and performance specifications at the time of release for distribution.This supplemental correction report is being filed to correct the report number in a previously submitted supplemental report (follow-up number 001) which was accepted by fda on 12/14/2018 03:28 pm ct.The report number is being corrected from: 3005099803-2018-61982 to: 3005099803-2018-60991.
|
|
Event Description
|
It was reported to boston scientific corporation on september 29, 2018 that a wallflex esophageal fully covered stent was to be used to treat a malignant stricture due to esophageal cancer during an endoscopic retrograde cholangiopancreatography (ercp) with esophageal stent placement procedure performed on (b)(6) 2018.Reportedly, the patient's anatomy was not tight and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent fell into the stomach right after it was deployed in the esophagus.The stent was removed with forceps and another wallflex esophageal stent was placed to complete the procedure.There were no patient complications reported as a result of this event.The patient's condition following the procedure was reported to be stable.
|
|
Search Alerts/Recalls
|
|
|